NL122325C - - Google Patents

Info

Publication number
NL122325C
NL122325C NL122325DA NL122325C NL 122325 C NL122325 C NL 122325C NL 122325D A NL122325D A NL 122325DA NL 122325 C NL122325 C NL 122325C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL122325C publication Critical patent/NL122325C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL122325D 1963-08-05 NL122325C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR943787A FR2913M (fr) 1963-08-05 1963-08-05 Nouveau médicament notamment pour le traitement des troubles de l'anabolisme protidique.

Publications (1)

Publication Number Publication Date
NL122325C true NL122325C (fr)

Family

ID=8809924

Family Applications (2)

Application Number Title Priority Date Filing Date
NL122325D NL122325C (fr) 1963-08-05
NL6408906A NL6408906A (fr) 1963-08-05 1964-08-04

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6408906A NL6408906A (fr) 1963-08-05 1964-08-04

Country Status (6)

Country Link
US (1) US3287221A (fr)
CH (1) CH417580A (fr)
DE (1) DE1468878B1 (fr)
FR (1) FR2913M (fr)
GB (1) GB1010080A (fr)
NL (2) NL6408906A (fr)

Also Published As

Publication number Publication date
NL6408906A (fr) 1965-02-08
DE1468878B1 (de) 1970-04-23
CH417580A (fr) 1966-07-31
GB1010080A (en) 1965-11-17
US3287221A (en) 1966-11-22
FR2913M (fr) 1964-11-09

Similar Documents

Publication Publication Date Title
FR6464M (fr)
BE627012A (fr)
BE603935A (fr)
BE629441A (fr)
BE625825A (fr)
BE624982A (fr)
NL122325C (fr)
BE624811A (fr)
BE645875A (fr)
BE645707A (fr)
BE645372A (fr)
BE645313A (fr)
BE645194A (fr)
BE645062A (fr)
NL6402200A (fr)
BE643528A (fr)
BE624070A (fr)
BE623490A (fr)
BE623315A (fr)
BE643256A (fr)
BE642537A (fr)
BE641714A (fr)
BE640815A (fr)
BE637202A (fr)
BE626986A (fr)